Buclizine dihydrochloride

CAS : 129-74-8

Ref. 3D-FB146989

Informations sur le produit

• Nom: Buclizine dihydrochloride
• Synonymes: 1-(4-(tert-Butyl)benzyl)-4-((4-chlorophenyl)(phenyl)methyl)piperazine dihydrochloride, 1-(4-Tert-Butylbenzyl)-4-[(4-Chlorophenyl)(Phenyl)Methyl]Piperazine Dihydrochloride, 1-(p-Chlorobenzhydryl)-4-(p-tert-butylbenzyl)diethylenediamine hydrochloride, 1-(p-tert-Butylbenzyl)-4-(p-chlorodiphenylmethyl)piperazine dihydrochloride, 1-p-Chlorobenzhydryl-4-p-(t)-butylbenzylpiperazine dihydrochloride, Aphilan R, Bucladin S, Buclina, Buclizine HCl, Buclizine Hydrochloride, Buclodin, Histabutyzine hydrochloride, Longifene, NSC 25141, Piperazine, 1-(p-tert-butylbenzyl)-4-(p-chloro-α-phenylbenzyl)-, dihydrochloride, Piperazine, 1-[(4-chlorophenyl)phenylmethyl]-4-[[4-(1,1-dimethylethyl)phenyl]methyl]-, dihydrochloride, Piperazine, 1-[(4-chlorophenyl)phenylmethyl]-4-[[4-(1,1-dimethylethyl)phenyl]methyl]-, hydrochloride (1:2), Softran, Ucb 4445, Vibazine, Vibazine Hydrochloride
• CAS: 129-74-8

Description

Buclizine is a tricyclic antidepressant that inhibits the activity of dopamine receptors. It can be used to treat nausea and vomiting, which are symptoms of many chronic diseases, including cancer. Buclizine also has anti-infectious effects and can inhibit the growth of bacteria by preventing their ability to synthesize DNA. This drug is used as an antimicrobial agent for the treatment of infectious diseases such as syphilis and leprosy. The hypoglycemic effect of buclizine may be due to its ability to inhibit insulin release or to decrease the production of glucose by liver cells.

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 505.95 g/mol
• Formule: C₂₈H₃₅Cl₃N₂
• Degré de pureté: Min. 98 Area-%
• Couleur/Forme: Powder